艾昆纬（IQVIA）：2026全球医药销售团队和营销渠道绩效年度回顾报告（英文版）（36页）.pdf

1、 2026.All rights reserved.IQVIA is a registered trademark of IQVIA Inc.in the United States,the European Union,and various other countries.An annual review of pharmaceutical sales force and marketing channel performanceChannelDynamicsGlobal Reference 2026:June ReportJAN 2025 DEC 2025Global2002About

2、ChannelDynamics004Summary009Global snapshots011Global data024Country data510OneKey515AppendixGlobal overview 2025011Investment by marketing channel012Investment by corporation,brand,therapy area013Sales force rep equivalents(FTE)014Analysis on the top 15 companies015Channel impact and reach016Omni p

3、ersonal vs.omni non-personal investment growth017Sales force effectiveness metrics018Source of digital engagement019Channel preference020Digital profile021Oncology investment by corporation,brand and cancer type022Channel volume trends023Net Promoter ScoreSM AnalysisNote:Net Promoter ScoreSM is serv

4、ice marks of Bain&Company,Inc.,NICE Systems,Inc.,and Fred Reichheld.IQVIA ChannelDynamics Global Reference 2026As part of IQVIAs Global Market Insights,ChannelDynamics offers marketing channel performance metrics across 36 countries.This publication provides an overview of 2025 pharmaceutical indust

5、ry marketing channel trends worldwide and at the country level.2026.All rights reserved.IQVIA is a registered trademark of IQVIA Inc.in the United States,the European Union,and various other countries.3IQVIA ChannelDynamicsAbout this publicationChannelDynamics is a syndicated database of projected p

6、romotional volume measures and channel performance metrics at company,indication and brand level.As standard,updated monthly and containing 7 years of historical data.Over 30,000 HCPs across 36 countries are recruited to ChannelDynamics specialist panels.Participants continuously fulfil an online da